PALLANTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.534
EU - Europa 9.419
AS - Asia 4.287
SA - Sud America 524
AF - Africa 126
OC - Oceania 123
Continente sconosciuto - Info sul continente non disponibili 72
Totale 27.085
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.362
PL - Polonia 2.802
RU - Federazione Russa 2.049
IT - Italia 2.041
SG - Singapore 1.283
CN - Cina 874
HK - Hong Kong 764
SE - Svezia 584
IE - Irlanda 574
VN - Vietnam 448
BR - Brasile 426
KR - Corea 384
UA - Ucraina 333
DE - Germania 305
FR - Francia 244
FI - Finlandia 207
GB - Regno Unito 148
IN - India 141
AU - Australia 120
BD - Bangladesh 102
CA - Canada 101
TR - Turchia 56
JO - Giordania 40
NL - Olanda 37
AR - Argentina 35
ID - Indonesia 35
ES - Italia 31
IQ - Iraq 30
NG - Nigeria 29
EC - Ecuador 26
JP - Giappone 25
CI - Costa d'Avorio 24
MX - Messico 19
PH - Filippine 17
SC - Seychelles 16
SA - Arabia Saudita 13
ZA - Sudafrica 13
JM - Giamaica 12
BE - Belgio 11
CO - Colombia 11
MA - Marocco 11
PK - Pakistan 11
VE - Venezuela 11
CH - Svizzera 10
UZ - Uzbekistan 10
KE - Kenya 9
TW - Taiwan 9
LT - Lituania 7
CL - Cile 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CR - Costa Rica 5
DZ - Algeria 5
GT - Guatemala 5
HN - Honduras 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
A1 - Anonimo 3
AT - Austria 3
BH - Bahrain 3
BO - Bolivia 3
DK - Danimarca 3
EU - Europa 3
KG - Kirghizistan 3
MU - Mauritius 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
TH - Thailandia 3
BB - Barbados 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SM - San Marino 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
Totale 27.000
Salva come PNG Salva come JPEG
Città #
Warsaw 2.798
Santa Clara 2.355
Fairfield 1.152
Ashburn 1.084
Singapore 892
Chandler 632
Hong Kong 612
Dublin 572
Jacksonville 549
Woodbridge 540
Seattle 493
Cambridge 478
Houston 405
Seoul 382
Wilmington 361
Milan 335
San Jose 320
Council Bluffs 223
Beijing 219
Florence 196
The Dalles 194
Rome 190
Princeton 188
Buffalo 168
Ann Arbor 161
Los Angeles 149
Ho Chi Minh City 143
Lauterbourg 141
Boston 122
Hefei 117
Melbourne 114
Altamura 109
Mumbai 106
Hanoi 103
Lawrence 90
New York 87
Boardman 84
San Diego 78
Phoenix 75
Medford 71
Dallas 69
Moscow 69
Naples 67
Clifton 53
Shanghai 50
Turin 39
Bologna 38
Helsinki 38
Kent 38
Columbus 35
Munich 35
Norwalk 35
São Paulo 33
Izmir 31
Dong Ket 30
Chicago 28
Toronto 28
Figino 27
Abuja 25
Jakarta 25
Abidjan 24
Falls Church 24
Verona 24
Frankfurt am Main 23
London 23
Redondo Beach 23
Bari 22
Guangzhou 21
Palermo 21
Tokyo 21
Barcelona 20
Genoa 20
Andover 19
Montreal 19
Orem 19
San Francisco 19
Brescia 18
Catania 18
Denver 17
Frankfurt Am Main 17
Paris 16
North Bergen 15
Tianjin 15
Brooklyn 14
Dearborn 14
Atlanta 12
Haiphong 12
Hillsboro 12
Pisa 12
Villejuif 12
Chennai 11
Falkenstein 11
Quarrata 11
Yubileyny 11
Amsterdam 10
Belo Horizonte 10
Guayaquil 10
Redmond 10
Venice 10
Amman 9
Totale 18.530
Salva come PNG Salva come JPEG
Nome #
Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines 361
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 358
Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation 350
Obsessive compulsive and related disorders: Comparing DSM-5 and ICD-11 336
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 329
Obsessive–Compulsive Disorder Comorbidity: Clinical Assessment and Therapeutic Implications 326
AWARENESS OF ILLNESS AND SUBJECTIVE EXPERIENCE OF COGNITIVE COMPLAINTS IN PATIENTS WITH BIPOLAR I AND BIPOLAR II DISORDER. 324
Relapse in young paranoid schizophrenic patients: a prospective study of stressful life events, P300 measures, and coping. 315
Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression 307
RAPID BENEFIT OF INTRAVENOUS PULSE LOADING OF CLOMIPRAMINE IN OBSESSIVE-COMPULSIVE DISORDER. 298
Prevalence and correlates of mental disorders in a school-survey sample. 294
OBSESSIVE COMPULSIVE DISORDER COMORBIDITY IN DBA 292
Transcranial magnetic stimulation for the treatment of pharmacoresistant nondelusional auditory verbal hallucinations in dementia 288
LITHIUM AND VALPROATE TREATMENT OF PATHOLOGICAL GAMBLING: A RANDOMIZED SINGLE-BLIND STUDY. 287
Phantom Limb Pain: Low Frequency Repetitive Transcranial Magnetic Stimulation in Unaffected Hemisphere 279
Separating hope from hype: some ethical implications of the development of deep brain stimulation in psychiatric research and treatment. 270
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD 268
Problematic internet use: is it more compulsory than rewarding or mood driven? 260
RELIABILITY AND VALIDITY OF THE PATHOLOGICAL GAMBLING ADAPTATION OF THE YALE-BROWN OBSESSIVE-COMPULSIVE SCALE (PG-YBOCS) 259
SHORT REPORT: AUTISTIC GASTROINTESTINAL AND EATING SYMPTOMS TREATED WITH SECRETIN: A SUBTYPE OF AUTISM 258
The Clinical Future of Repetitive Transcranial Magnetic Stimulation and Depression: Separating Hope From Hype 247
Resistant social anxiety disorder response to Escitalopram 247
The relationship between impulse-control disorders and obsessive–compulsive disorder: A current understanding and future research directions 243
Think twice: Impulsivity and decision making in obsessive-compulsive disorder 234
Comprehensive care of schizophrenia: a textbook of clinical management, 2nd edition. 234
Efficacy of high-frequency (15 Hz) repetitive transcranial magnetic stimulation (rTMS) of the left premotor cortex/dorsolateral prefrontal cortex in decreasing cocaine intake (the MagneTox study): A study protocol for a randomized placebo-controlled pilot trial 226
Familiarità, eventi di vita stressanti, stili parentali,temperamento e asse HPA: i possibili determinanti dei disturbi psichiatrici? 225
RTMS in resistant mixed states: An exploratory study 223
Comorbidity in obsessive-compulsive disorder (OCD): A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 222
Efficacy of a vegetal mixture composed of Zingiber officinale, Echinacea purpurea, and Centella asiatica in a mouse model of neuroinflammation: In vivo and ex vivo analysis 217
Enhancing cognitive-behavioral therapy with repetitive transcranial magnetic stimulation in refractory obsessive-compulsive-disorder: A case report 212
Complex repetitive behavior: Punding after bilateral subthalamic nucleus stimulation in Parkinson's disease 211
Deep Brain Stimulation of the Anterior Limb of the Internal Capsule May Be Efficacious for Explosive Aggressive Behaviour 207
From ‘mental fog’ to post-acute COVID-19 syndrome's executive function alteration: Implications for clinical approach 204
5-HT(1D) function and repetitive behaviors 202
Psichiatria elementare 201
New treatment models for compulsive disorders 200
BASIC SYMPTOMS AND P300 ABNORMALITIES IN YOUNG SCHIZOPHRENIC PATIENTS. 199
Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics 194
Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study. 192
Autoimmune markers in vitiligo patients appear correlated with obsession and phobia 191
A randomised, double-blind, sham-controlled study of left prefrontal cortex 15 Hz repetitive transcranial magnetic stimulation in cocaine consumption and craving 190
Pharmacologic treatment of obsessive-compulsive disorder comorbidity 188
Patients’ experience of screening CT colonography with reduced and full bowel preparation in a randomised trial 188
EMOTIONAL AROUSAL AND PHOBIA IN TRANSIENT GLOBAL AMNESIA 185
Absence of APP713 mutation in Italian and Russian families with schizophrenia. 182
Anxiety as a core aspect of schizophrenia 181
Outcomes with neuromodulation in obsessive- compulsive disorder. 181
A QUALITATIVE ANALYSIS OF NONRESPONSE: MANAGEMENT OF TREATMENT-REFRACTORY OBSESSIVE-COMPULSIVE DISORDER. 180
Abnormal visual event-related potentials in obsessive-compulsive disorder without panic disorder or depression comorbidity 180
EPIDEMIOLOGY OF MOOD DISORDERS:A COMMUNITY SURVEY IN FLORENCE 180
Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity 180
No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees. 179
Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial 178
A SETTING INCLUDING PSYCHOTHERAPY AND PSYCHOPHARMACOLOGICAL TREATMENT IN A CASE OF ANOREXIA NERVOSA WITH OBSESSIVE-COMPULSIVE DISORDER COMORBIDITY 177
CITALOPRAM FOR TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER. 175
Freud a Firenze. 175
Facial Affect Recognition in CADASIL Patients. 175
The Specific Level of Functioning Scale: Construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community 173
Emerging drugs to treat obsessive-compulsive disorder 173
DEPRESSIVE RELAPSES AND INCOMPLETE RECOVERY FROM INDEX EPISODE 172
[Validity and reliability of Quality of Life, Enjoyment and Satisfaction Questionnaire, Short Form]. 172
Abstract #59: Modulating Inhibitory Control Networks in Gambling Disorder with Theta Burst Stimulation 171
ATTACHMENT PROCESS IN EATING DISORDERS 170
A double-blind, placebo-controlled trial of topiramate for pathological gambling 168
SMOOTH-PURSUIT EYE MOVEMENT AND SACCADIC INTRUSIONS IN OBSESSIVE-COMPULSIVE DISORDER. 166
Social anxiety in outpatients with schizophrenia: a relevant cause of disability. 165
An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder. 163
PULSE LOADING VERSUS GRADUAL DOSING OF INTRAVENOUS CLOMIPRAMINE IN OBSESSIVE-COMPULSIVE DISORDER. 162
BRAIN PLASTICITY AND BRAIN STIMULATION IN NEUROPSYCHIATRY:TOWARD INDIVIDUALIZED MEDICINE 162
EYE MOVEMENT ABNORMALITIES IN ANOREXIA NERVOSA. 160
Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). 157
Smooth-pursuit eye movements: alterations in Alzheimer's disease. 156
Motor cortex excitability correlates with novelty seeking in social anxiety: a transcranial magnetic stimulation investigation. 156
The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) 156
NORADRENERGIC FUNCTION IN PATHOLOGICAL GAMBLING:BLUNTED GROWTH HORMONE RESPONSE TO CLONIDINE 155
rTMS age-dependent response in treatment-resistant depressed subjects: a mini-review. 155
Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses 154
Validity and reliability of the italian version of the quality of life, enjoyment and satisfaction questionnaire 154
Streptococcal infections of skin and PANDAS 151
Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview 150
Panic attacks with and without agoraphobia: a comparison. 149
PSYCHONEUROIMMUNODERMATOLOGY OF ATOPIC DERMATITIS: FROM EMPIRIC DATA TO THE EVOLUTIONARY HYPOTHESIS 148
The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) 148
PSYCHOSOMATIC FACTORS IN DERMATOLOGY 147
TRANSCULTURAL OBSERVATIONS OF OBSESSIVE-COMPULSIVE DISORDER 147
Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan 146
ICD and DSM: Neuroplasticity and staging are still missing 146
KLEPTOMANIA: CLINICAL FEATURES AND COMORBIDITY IN AN ITALIAN SAMPLE. 145
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 144
Cigarette smoking in patients with obsessive compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) 144
THE EMERGENCE OF SOCIAL PHOBIA DURING CLOZAPINE TREATMENT AND ITS RESPONSE TO FLUOXETINE AUGMENTATION. 142
RISPERIDONE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. 142
PERSONALITY DISORDERS:MYTHS AND NEUROSCIENCE 141
FDG-PET STUDY IN PATHOLOGICAL GAMBLERS 141
MDMA (ECSTASY) PRECIPITATION OF PANIC DISORDER 140
Can we modulate obsessive-compulsive networks with neuromodulation? 140
INTRAVENOUS CLOMIPRAMINE CHALLENGE IN OBSESSIVE-COMPULSIVE DISORDER: PREDICTING RESPONSE TO ORAL THERAPY AT EIGHT WEEKS 140
PERCEPTION OF EARLY PARENTING IN PANIC AND AGORAPHOBIA 138
Transcranial Magnetic Stimulation in Alzheimer's Disease: A Review of Investigational and Therapeutic Findings. 138
Totale 20.111
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022882 0 0 66 45 49 48 29 63 54 56 172 300
2022/20232.498 336 296 77 208 211 492 312 164 235 45 91 31
2023/2024896 48 117 192 59 54 92 77 147 11 40 32 27
2024/20256.409 250 667 411 806 1.993 906 79 485 291 163 178 180
2025/20266.273 578 838 452 356 603 228 766 378 393 355 238 1.088
2026/20271.204 415 326 463 0 0 0 0 0 0 0 0 0
Totale 27.085